Each B-cell receptor consists of a pair of heavy and light chains. High-throughput sequencing can identify large numbers of heavy-and light-chain variable regions (V H and V L ) in a given B-cell repertoire, but information about endogenous pairing of heavy and light chains is lost after bulk lysis of B-cell populations. Here we describe a way to retain this pairing information. In our approach, single B cells (>5 × 10 4 capacity per experiment) are deposited in a high-density microwell plate (125 pl/well) and lysed in situ. mRNA is then captured on magnetic beads, reverse transcribed and amplified by emulsion V H :V L linkage PCR. The linked transcripts are analyzed by Illumina high-throughput sequencing. We validated the fidelity of V H :V L pairs identified by this approach and used the method to sequence the repertoire of three human cell subsets-peripheral blood IgG + B cells, peripheral plasmablasts isolated after tetanus toxoid immunization and memory B cells isolated after seasonal influenza vaccination.
l e t t e r s
Each B-cell receptor consists of a pair of heavy and light chains. High-throughput sequencing can identify large numbers of heavy-and light-chain variable regions (V H and V L ) in a given B-cell repertoire, but information about endogenous pairing of heavy and light chains is lost after bulk lysis of B-cell populations. Here we describe a way to retain this pairing information. In our approach, single B cells (>5 × 10 4 capacity per experiment) are deposited in a high-density microwell plate (125 pl/well) and lysed in situ. mRNA is then captured on magnetic beads, reverse transcribed and amplified by emulsion V H :V L linkage PCR. The linked transcripts are analyzed by Illumina high-throughput sequencing. We validated the fidelity of V H :V L pairs identified by this approach and used the method to sequence the repertoire of three human cell subsets-peripheral blood IgG + B cells, peripheral plasmablasts isolated after tetanus toxoid immunization and memory B cells isolated after seasonal influenza vaccination.
Next-generation sequencing of immunoglobulin variable region and T-cell receptor repertoires is providing information that is key to understanding adaptive immune responses and to diagnostic and therapeutic applications [1] [2] [3] [4] [5] [6] . However, existing immune repertoire sequencing technologies yield data on only one of the two chains of immune receptors and thus cannot provide information about the identity of immune receptor pairs encoded by individual B or T lymphocytes 2, 7, 8 . Sequence analysis of V H :V L pairs is currently done by microtiterwell sorting of individual B cells followed by single-cell RT-PCR (scRT-PCR) and Sanger sequencing [8] [9] [10] [11] [12] [13] [14] [15] ; however, at most a few hundred V H :V L pairs (a number dwarfed by the enormous size of the human antibody repertoire) are identified by means of scRT-PCR [11] [12] [13] [14] . Microfluidic methods for RT-PCR and the sequencing of two or more genes (e.g., using the Fluidigm platform 16 ) have so far been limited to only 96 wells per run and require complex, proprietary instrumentation. As a result, comprehensive analysis of paired V H :V L gene family usage and somatic hypermutation frequency has been elusive.
Here we report the development, validation and application of an accessible and scalable technology for the high-throughput sequencing of V H :V L pairs from individual human B lymphocytes. We used this technology to determine the V H :V L repertoires of several human B-cell subpopulations of particular interest, namely peripheral class-switched B cells in healthy individuals, memory B cells after influenza vaccination and antigen-specific plasmablasts after tetanus toxoid (TT) immunization. We applied this technology to discover high-affinity, antigen-specific human antibodies from the sequenced plasmablasts.
In this approach, a population of sorted B cells was deposited by gravity into 125-pl wells molded in polydimethylsiloxane (PDMS) slides (Fig. 1) . Each slide contained 1.7 × 10 5 wells; four slides processed concurrently accommodated 68,000 lymphocytes at a ≥1:10 cell/well occupancy, which gave at least a 95% probability of there being only one cell per well based on Poisson statistics. Poly(dT) magnetic beads with a diameter of 2.8 µm were deposited into the microwells at an average of 55 beads/well and the slides were covered with a dialysis membrane. Subsequently, the membrane-covered slides were incubated with an optimized cell lysis solution containing 1% lithium dodecyl sulfate that resulted in complete cell lysis within <1 min (Supplementary Video 1) . The mRNA annealed to the poly(dT) magnetic beads, which were then collected, washed and emulsified with primers, reverse transcriptase and thermostable DNA polymerase to carry out reverse transcription followed by linkage PCR (Supplementary Fig. 1 ). The two-step capture and amplification process ( Fig. 1) was necessary because single-compartment cell lysis followed by RT-PCR has not proven feasible in volumes ≤5 nl because of inhibition of the reverse transcription reaction by cell lysate constituents. In addition, performing V H :V L linkage in emulsion droplets containing single cells would necessitate cell entrapment, lysis, reverse transcription and in situ-linkage PCR that can only be done in microfluidic devices, a strategy that requires extensive infrastructure and has been reported to have limited throughput at ≤300 cells per run 17 . PCR amplification generated an ~850-base pair (bp) linked V H :V L l e t t e r s DNA product composed of (from 5′ to 3′) the N-terminal end of CH 1 , the V H , a linker region, the V L and the N terminus of C κ or C λ (Supplementary Fig. 1) . The most informative 500 bp of this fragment, which encompassed the complementarity determining regions (CDR-H3 and CDR-L3), was then sequenced on a long-read nextgeneration sequencing platform such as the 2 × 250 Illumina MiSeq (which also provided the framework region FR3 and FR4 sequences and constant region N termini amino acid sequences that can be used for isotype assignment). If FR1 to CDR2 region sequences were also desired, the V H and V L gene repertoires were analyzed by separate 2 × 250-bp sequencing runs. This latter step was required because of readlength limitations with existing technology; whereas single-molecule sequencing techniques allow for longer reads, the error rate is too high to enable robust classification of V H :V L sequences.
We employed the methodology of Figure 1 to determine the V H : V L repertoire of three different B-cell populations of relevance to human immunology and antibody discovery. First, we isolated IgG + B cells from fresh blood donated by a healthy individual. We spiked 61,000 IgG + B cells with immortalized IM-9 lymphoblast cells (to ~4% of total mixture) that express known V H and V L sequences as an internal control. We analyzed these cells in four PDMS slides (6.8 × 10 5 total wells). After 2 × 250 MiSeq sequencing, we clustered the CDR-H3 regions based on 96% sequence identity, consistent with the established error rate of the MiSeq platform, to determine the number of unique clones recovered from this human sample. A total of 2,716 unique pairs were thus identified (Supplementary Table 1 ). The spiked IM-9 heavy chain overwhelmingly (78-fold above background) paired with its known light chain. A heat map shows frequencies of pairing between V H and V L segments of different germline families in the class-switched IgG + cell repertoire (Fig. 2a) . A second IgG + repertoire analysis was done using B cells from another anonymous individual; this analysis identified 2,248 unique CDR-H3 from 47,000 IgG + cells, and the IM-9 control spike again demonstrated high pairing accuracy (125-fold above background; Supplementary Fig. 2 and Supplementary Table 2 ). Several V gene families (e.g., IGHV7; IGKV5, 6, and 7; IGLV4, 10, and 11) are expressed at very low frequencies in the human immune repertoire 3, 18 . We detected V H :V L pairs containing these rare families, indicating that this technique can identify rare B-cell clones present at physiological levels together with much more abundant clones (e.g., the much more highly used IGHV3 or IGHV4 families; Fig. 2a and Supplementary Fig. 2 ). Interestingly, the V H :V L germline pairing frequencies were highly correlated between the two individuals (Spearman rank correlation coefficient = 0.804; P < 10 −29 ); the most highly transcribed heavy chain genes (IGHV3, IGHV4 and IGHV1 families) paired most frequently with the most highly transcribed light chain genes (IGKV1, IGKV3, IGLV1 and IGLV2 families). However, putative differences in IgG + V H :V L germline pairing frequencies between the two individuals were also evident.
In a separate experiment, human plasmablasts (CD19 + CD3 − CD14 − CD38 ++ CD27 ++ CD20 − ) from a healthy volunteer were collected 7 d after TT immunization, sorted for surface antigen binding and then frozen 12 . After thawing, ~400 recovered cells were spiked with the immortalized ARH-77 cell line as an internal control and seeded onto a single PDMS slide (1.7 × 10 5 total wells). In this instance, 86 unique primary CDR-H3:CDR-L3 pairs were identified, and the ARH-77 control spike demonstrated high pairing accuracy ( Fig. 2b and Supplementary Table 1) . We expressed ten of the identified V H : V L pairs as IgG proteins in HEK293K cells. As revealed by competitive enzyme-linked immunosorbent assay (ELISA), all ten antibodies showed specificity for TT and bound TT with high affinity (0.1 nM ≤ K D ≤ 18 nM; Table 1 ; antibody sequences provided in Supplementary Data). Whereas certain V H chains can pair promiscuously with multiple V L s to yield functional antibodies, it is statistically implausible that 10/10 antibodies could display nM and sub-nM affinities for TT merely as a consequence of fortuitous V H :V L pairing. For comparison, 10-15% of antibodies generated by random pairing of V H genes with a small set of enriched V L genes were antigen-specific 19, 20 .
Finally, we compared the V H :V L pairings identified using this high-throughput approach to those identified using the established single-cell sorting method 11, 21 ; this experiment was conducted in a double-blinded manner. Peripheral CD19 + CD3 − CD27 + CD38 int memory B cells were isolated from a healthy volunteer 14 d after vaccination with the 2010-2011 trivalent FluVirin influenza vaccine 21 . For the scRT-PCR analysis, 168 single B cells were sorted into four 96-well plates, and 168 RT and 504 nested PCR reactions were carried out individually to separately amplify the V H and V L (κ and λ) genes. DNA products were resolved by gel electrophoresis and sequenced to yield a total of 51 V H :V L pairs, of which 50 were unique. A separate B-cell aliquot from the same individual was frozen at −80 °C and later thawed and processed using the new high-throughput approach described here. Two PDMS slides (3.4 × 10 5 total wells) were used, and the sample was spiked with IM-9 cells to confirm pairing accuracy (Supplementary Table 1 ). A total of 240 unique CDR-H3:CDR-L3 pairs were recovered (Fig. 2c) . Four CDR-H3 sequences detected in the high-throughput pairing set were also observed in the single-cell RT-PCR analysis. A blinded analysis revealed that CDR-H3:CDR-L3 pairs isolated by the two approaches were in complete agreement Table 3 , sequences provided in Supplementary Data and repertoire comparisons in Supplementary Fig. 3) . Further, the one V H :V L pair detected in more than one of the 51 cells analyzed by single-cell RT-PCR was also detected in the aliquot processed by the new high-throughput approach (clone 2D02 was observed in two cells by scRT-PCR, Supplementary Table 3); these findings suggest that this B-cell clone may have undergone a great deal of expansion. The 46 V H genes that were each observed only once by single-cell RT-PCR but that were not detected in the aliquot processed by our high-throughput approach presumably represent unique or very low abundance B-cell clones, as expected given the great degree of V gene diversity normally found in human peripheral memory B cells.
In these experiments the control cell lines spiked into each aliquot of primary B cells were selected to approximate the levels of heavy chain and light chain transcription in that particular primary B-cell subpopulation. For example, the ARH-77 cell line expressed high levels of heavy chain and light chain transcripts and therefore was spiked into plasmablast populations that also express abundant heavy chain and light chain transcripts; in contrast, the IM-9 B lymphoblast cell line, which expresses lower levels of heavy chain and light chain transcripts, was spiked into memory B-cell populations. Known V H and V L sequences from spiked-in control cell lines were used to evaluate the frequency of non-native pairings, that is, the false discovery rate (FDR). The FDR, determined from the mispairing of spiked-in control V H and V L chains, was commensurate with the probability of coincident cells per well, which in turn is dictated by cell seeding density and follows Poisson statistics (Online Methods and Supplementary Table 4 ). The FDR revealed by the mispairing frequency of control cell lines represents the upper bound of the FDR, as the control cell lines were introduced at levels over tenfold higher than the levels at which even a very highly expanded B-cell clone might be present in a biological sample in humans. Although currently V H :V L pairing efficiency in memory B-cell populations is relatively modest (Fig. 2 and Supplementary  Fig. 2 ), efforts to further improve efficiency are under way.
The high-throughput V H :V L pairing technique described here requires one emulsion RT-PCR reaction, followed by nested PCR, sequencing and bioinformatic analysis. The entire process from B-cell isolation to the generation of V H :V L heat maps can be completed by a single investigator in 10 research hours over the course of 4 d (which includes 3 d for gene sequencing). For example, the work required to recover 2,716 unique V H :V L pairs from a sample of IgG + peripheral B cells (Fig. 2a) was completed by a single researcher in 10 h and cost $550. Analysis of 2,700 cells using established optimal single-cell RT-PCR protocols would have required >10 weeks of effort by an experienced technician and >$25,000 in reagent and sequencing costs 11 .
Because only sequences of up to 500 bp can be accurately determined with current Illumina next-generation sequencing technology, our method detects the different antibody clonotypes (antibodies comprising the same CDR-H3:CDR-L3) but cannot yet distinguish somatic variants originating from clonally related B cells that contain upstream mutations between FR1 and CDR2 regions. However, this method distinguished nearly identical but distinct CDR3 regions, as indicated by B-cell clones 2D02 and 3D05, which express light chain CDR3s that differ by only two nucleotides (Supplementary Table 3 ). Rapid advances in next-generation sequencing read-length and quality will likely enable upstream somatic variant analysis in the near future.
We used PCR amplification primers targeted to the FR1 region of heavy and light chains (primers reported in Supplementary  Tables 5-7) . In some chronic infections (e.g., HIV), constant antigen exposure can generate antibodies that are highly mutated in all regions including the FR1 region, and therefore amplification with FR1-specific primers can bias the repertoire. In these cases, such bias can be readily circumvented by using primers that anneal to the leader peptide 22 .
Finally, we note that the analysis reported here focused on the light chain that was the dominant light chain paired with a particular V H . There are known, albeit rare, instances in mice where one heavy chain can be found paired with more than one light chain 23 . Bioinformatic analysis might discriminate between biologically relevant V H :V L pairs of one heavy chain with multiple light chains and false pairings that might result from multiple cells seeded into the same well of the This accessible technology for sequencing the paired V H :V L repertoire enables rapid interrogation of the immune response and can be applied to investigate B-cell maturation, vaccine efficacy, immune system health and autoimmunity in clinical and research settings. The high-throughput identification and cloning of paired V H :V L antigenspecific antibodies from responding B cells may also enable rapid generation of novel diagnostic, therapeutic or prophylactic antibodies.
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oNLINE METHoDS
Preparation of microwell slides. A grid of micropillars (56-µm diameter, 50-µm height) was photolithographically patterned onto a silica wafer using SU-8 photoresist (Fisher Scientific, Pittsburgh, PA) and the silica wafer was used as a mold to print PDMS slides (Sylgard 184, Dow Corning, Midland, MI) with the dimensions of a standard microscope slide and containing ~170,000 wells each.
Molded PDMS slides were treated in an oxygen plasma chamber for 5 min to generate a hydrophilic surface. The PDMS slides were blocked in 1% BSA for 30 min and washed with deionized water followed by PBS to prepare for cell seeding. Frozen PBMCs were subsequently thawed and cell suspensions were stained in PBS/0.2% BSA with anti-human CD19 (HIB19, BioLegend, San Diego, CA), CD27 (O323, BioLegend), CD38 (HIT2, BioLegend) and CD3 (7D6, Invitrogen, Grand Island, NY). CD19 + CD3 − CD27 + CD38 int memory B cells were sorted using a FACSAria II sorter system (BD Biosciences, San Diego, CA). Cells were either cryopreserved in DMSO/10% FCS for subsequent high-throughput V H : V L pairing or single-cell sorted into 96-well plates containing RNAse Inhibitor Cocktail (Promega, Madison, WI) and 10 mM Tris-HCl pH 8.0 for single-cell RT-PCR analysis. cDNA was synthesized from single-sorted cells using the Maxima First Strand cDNA Synthesis Kit (Fermentas, Waltham, MA) followed by amplification of the immunoglobulin variable genes using primer sets and PCR conditions previously described 11 . Variable genes were determined with in-house analysis software using the IMGT search engine 24 .
Analysis of memory B-cell V
Memory B cells frozen for high-throughput V H :V L pairing were thawed and recovered by centrifugation at 250g for 10 min. Cells were resuspended in 200 µl RPMI-1640 supplemented with 1× GlutaMAX, 1× non-essential amino acids, 1× sodium pyruvate and 1× penicillin/streptomycin (Life Technologies) and incubated at 37 °C for 13 h in a 96-well plate. Recovered cells were centrifuged again at 250g for 10 min and resuspended in 400 µl PBS, and 6 µl were withdrawn for cell counting with a hemocytometer. Approximately 8,800 cells were recovered from frozen stock. Memory B cells were then spiked with ~880 IM-9 cells (ATCC number CCL-159) as an internal control. Cells were resuspended over two PDMS microwell slides (340,000 wells) and allowed to settle into wells by gravity over the course of 5 min with gentle agitation. The cell seeding process has been calculated to be 90% efficient by measuring cell concentration in seeding buffers both pre-and post-cell seeding; thus 8,000 primary cells were analyzed in this experiment. The fraction of cells isolated in the single and multiple cell per well states was calculated using Poisson statistics
where k equals the number of cells in a single microwell and µ is the average number of cells per well, so that the 1:39 cell:well ratio used in this experiment corresponds to 98.7% of cells deposited at an occupancy of one cell/well. We resuspended 25 µl of poly(dT) magnetic beads (Invitrogen mRNA Direct Kit) in 50 µl PBS and distributed over each PDMS slide surface, (mean of 55 poly(dT) beads per well). Magnetic beads were allowed to settle into wells by gravity for ~5 min, then a BSA-blocked dialysis membrane (12,000-14,000 MWCO regenerated cellulose, 25-mm flat width, Fisher Scientific) that had been rinsed in PBS was laid over each slide surface, sealing the microwells and trapped cells and beads inside. Excess PBS was removed from the slide and membrane surfaces using a 200 µL pipette. 500 µL of cell lysis solution (500 mM LiCl in 100 mM TRIS buffer (pH 7.5) with 1% lithium dodecyl sulfate, 10 mM EDTA and 5 mM DTT) was applied to the dialysis membranes for 20 min at room temperature. Time-lapse microscopy revealed that all cells are fully lysed within 1 min (Supplementary Video 1) . Subsequently the slides were incubated at 4 °C for 10 min at which point a Dynal MPC-S magnet was placed underneath the PDMS microwell device to hold magnetic beads inside the microwells as the dialysis membrane was removed with forceps and discarded. Working quickly, the PDMS slides were sequentially inverted in a Petri dish containing 2 mL of cold lysis solution and the magnet was applied underneath the Petri dish to force the beads out of the microwells. Subsequently, 1 ml aliquots of the lysis solution containing resuspended beads were placed into Eppendorf tubes and beads were pelleted on a Dynal MPC-S magnetic rack and washed once without resuspension using 1 mL per tube of wash buffer 1 (100 mM Tris, pH 7.5, 500 mM LiCl, 1 mM EDTA, 4 °C). Beads were resuspended in wash buffer 1, pelleted and resuspended in wash buffer 2 (20 mM Tris, pH 7.5, 50 mM KCl, 3 mM MgCl) and pelleted again. Finally beads were suspended in 2.85 mL cold RT-PCR mixture (Quanta OneStep Fast, VWR) containing 0.05 wt% BSA (Invitrogen Ultrapure BSA, 50 mg/mL) and primer sets for V H and V L linkage amplification ( Supplementary Fig. 1 and Supplementary anti-Digoxigenin-FITC (Roche, labeled at the DRFZ) and DAPI was added before sorting. CD19 + CD3 − CD14 − CD38 ++ CD27 ++ CD20 − TT + plasmablasts were sorted using a FACSAria II sorter system (BD Biosciences). A portion of sorted cells were washed and cryopreserved in DMSO/10%FCS for highthroughput V H :V L pairing. One vial containing approximately 2,000 frozen TT + plasmablasts was thawed and recovered by centrifugation at 250g for 10 min, for which 20-30% recovery was anticipated 27 . Cells were resuspended in 300 µL RPMI-1640 supplemented with 10% FBS, 1× GlutaMAX, 1× non-essential amino acids, 1× sodium pyruvate and 1× penicillin/streptomycin (all from Life Technologies) and incubated at 37 °C for 13 h in a 96-well plate. Recovered cells were centrifuged again at 250g for 10 min and resuspended in 400 µL PBS, and 6 µL were withdrawn for cell counting with a hemocytometer. Cells were spiked with approximately 30 ARH-77 cells as an internal control (ATCC number CRL-1621) and V H :V L transcripts were linked as described above, omitting IgM primers and using a 38-cycle nested PCR; the resulting product was submitted for 2 × 250 MiSeq sequencing. V H and V L chains were also amplified individually to obtain full V H and V L sequences for antibody expression. Nested PCR product was diluted 1:9 and 0.5 µL were used as template in a PCR reaction with the following conditions: 400 nM primers (Supplementary Table 7) , 2 min initial denaturation at 94 °C, denaturation at 94 °C for 30 s for 12 cycles, annealing at 62 °C for 30 s and extension at 72 °C for 15 s, final extension at 72 °C for 7 min. The resulting ~450 bp V H or ~400 bp V L products were purified by agarose gel electrophoresis and submitted for 2 × 250 MiSeq sequencing.
Ten V H and V L pairs (Supplementary Data, .fna file) were selected from TT + plasmablast pairings and cloned into the human IgG expression vectors pMAZ-VH and pMAZ-VL, respectively 28 . 40 µg each of circularized ligation product were co-transfected into HEK293F cells (Invitrogen, NY, USA). Medium was harvested 6 d after transfection by centrifugation and IgG was purified by a protein-A agarose (Pierce, IL, USA) chromatography column.
Antigen affinities were determined by competitive ELISA 29 using different concentrations of IgG in a serial dilution of antigen, ranging from 100 nM to 0.05 nM in the presence of 1% milk in PBS. Plates were coated overnight at 4 °C with 10 µg/mL of TT in 50 mM carbonate buffer, pH 9.6, washed three times in PBST (PBS with 0.1% Tween 20) and blocked with 2% milk in PBS for 2 h at room temperature. Pre-equilibrated samples of IgG with TT antigen were added to the blocked ELISA plate, incubated for 1 h at room temperature, and plates were washed 3× with PBST and incubated with 50 µl of anti-human kappa light chain-HRP secondary antibody (1:5,000, 2% milk in PBS) for ~2 min, 25 °C. Plates were washed 3× with PBST, then 50 µl Ultra TMB substrate (Thermo Scientific, Rockford, IL) was added to each well and incubated at 25 °C for 5 min. Reactions were stopped using equal volume of 1M H 2 SO 4 and absorbance was read at 450 nm (BioTek, Winooski, VT). Each competitive ELISA replicate was fit using a four-parameter logistic (4PL) equation, with error represented as the s.d. of 2-3 replicates for each IgG analyzed.
Analysis of IgG + class switched cells in healthy donor peripheral blood. PBMC from two different anonymous healthy donors (Texas Gulf Coast Regional Blood Center) were isolated from whole blood using Histopaque-1077 centrifugation gradient (Sigma-Aldrich) according to manufacturer protocols. 3.8 × 10 8 PBMCs were used as input for cell purification using a IgG + Memory B Cell Isolation Kit (Miltenyi Biotec, Auburn, CA). Approximately 68,000 cells (Fig. 2a) or 52,000 cells (Supplementary Fig. 2) were spiked with 4% IM-9 immortalized B lymphoblast cells (ATCC number CCL-159) and seeded onto four or three PMS microwell slides, respectively, at a 1:10 cell/well ratio corresponding to 95.1% of cells isolated as single cells by Poisson distribution. Cell seeding was calculated to be 90% efficient and thus 61,000 cells ( Fig. 2a and Supplementary Table 1) or 47,000 cells ( Supplementary  Fig. 2 and Supplementary Table 2) were analyzed. V H :V L chains were paired and amplified as above using 35 nested PCR cycles and sequenced on the Illumina MiSeq platform.
Bioinformatic methods. Raw 2 × 250 MiSeq data were filtered for minimum Phred quality score of 20 over 50% of nucleotides to ensure high read quality in the CDR3-containing region (approximately HC nt 65-115 or LC nt 55-100). Sequence data were submitted to the International ImMunoGeneTics Information System (IMGT) for mapping to germline V(D)J genes 30 . Sequence data were filtered for in-frame V(D)J junctions, and productive V H and V κ,λ sequences were paired by Illumina read ID. CDR-H3 nucleotide sequences were extracted and clustered to 96% nt identity with terminal gaps ignored, to generate a list of unique CDR-H3s in the data set. 96% nt identity cutoff was found to be the optimal cutoff to cluster sequencing error in spiked control clones; the number of unique CDR-H3 sequences and hence the number of unique V genes reported refer to the number of clusters recovered from the sample (Supplementary Table 1  and Supplementary Table 2) . Overwhelmingly, the frequency of the top V L pair for a given V H was observed to be greater than 90%, and the top V L pair for each CDR-H3 was used for comparison with single-cell RT-PCR for workflow validation (Supplementary Table 3) , consensus sequence generation and paired V H :V L expression ( Table 1) , and V H :V L gene family heat maps (Fig. 2 and Supplementary Figs. 2 and 3) . In the case of separate V H and V L gene amplification for complete antibody sequencing, 2 × 250 bp reads containing the 5′ V gene FR1-CDR2 and 3′ CDR2-FR4 were paired by Illumina read ID and consensus sequences were constructed from reads containing the exact CDR3 of interest.
